$6.99 0.10 (+1.45%)
12/4/2009 9:37 AM

Exelixis, Inc. (EXEL)

CAPS Rating: 5 out of 5

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Recs

3
Member Avatar zzlangerhans (99.57) Submitted: 10/16/2008 11:33:48 AM : Outperform Start Price: $4.14 EXEL Score: +23.40

Ah, Exelixis. You've broken so many hearts over the years. With your ever-widening and never-lengthening pipeline, sometimes you seem like you're already the biotech subdivision of a large pharmaceutical company. Is that what your dream is? Now that your cap is below 400M you may finally achieve it. I finally see a price I like, and I'll let myself be seduced again with my eyes on the prize of being your master.

Report this Post 1 Comment
Member Avatar zzlangerhans (99.57) Submitted: 3/2/2009 2:31:54 PM
Recs: 0 Rec This

I want to try getting Exelixis below 4.

Report this Post

Featured Broker Partners